US Map / Kentucky
State KY

Clinical Trials in Kentucky

Recruiting clinical trials with at least one study location in Kentucky. Data updated daily from ClinicalTrials.gov.

Total Trials
132
Recruiting Now
132
← Back to US Map
Top Conditions in Kentucky
Malignant Solid Neoplasm (6)Acute Myeloid Leukemia (3)Atopic Dermatitis (3)Melanoma (2)Lung Cancer (2)Hematopoietic and Lymphatic System Neoplasm (2)Migraine (2)Multiple Myeloma (2)Acute Lymphoblastic Leukemia (2)Chronic Lymphocytic Leukemia (2)Hematopoietic and Lymphoid Cell Neoplasm (2)Asthma (2)
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT02708134 N/A
Recruiting
Quality of Pediatric Resuscitation in a Multicenter Collaborative
Condition
Cardiac Arrest
Enrollment
7,000 pts
Location
United States, Australia, Brazil
Sponsor
Children's Hospital of Philade
View Trial →
NCT01719055 N/A
Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-T...
Condition
Pain
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
Boston Scientific Corporation
View Trial →
NCT05948540 Phase 2
Recruiting
Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexa...
Condition
Post Traumatic Stress Disorder
Enrollment
200 pts
Location
United States
Sponsor
Global Coalition for Adaptive
View Trial →
NCT05773274 Phase 2
Recruiting
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patie...
Condition
Metastatic Digestive System Neuroendocrine Tumor G1
Enrollment
100 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT05983250 Phase 3
Recruiting
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Condition
Pulmonary Hypertension
Enrollment
230 pts
Location
United States, Canada
Sponsor
Tenax Therapeutics, Inc.
View Trial →
Page 6 of 6 — 132 trials total
← Prev